Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (12 quarters reported)
$330M in Q4 2013 → $16M now. Hover for any quarter.
As reported for the quarter ended September 30, 2016. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Edwards Lifesciences Corp | 26.1% | Added 86% | 34,611 | $4.17M |
| Acadia Pharmaceuticals Inc | 14.5% | Trimmed 12% | 72,723 | $2.31M |
| AT Aratana Therapeutics Inc | 12.8% | Unchanged | 218,515 | $2.05M |
| Johnson & Johnson | 9.6% | Unchanged | 13,000 | $1.54M |
| Dexcom Inc | 7.8% | Added 21% | 14,200 | $1.25M |
| LE Lilly Eli & Co | 6.7% | Trimmed 50% | 13,310 | $1.07M |
| T Tesaro Inc | 6.3% | New | 10,000 | $1M |
| Zoetis Inc | 5.2% | New | 15,900 | $827K |
| Biogen Inc | 5.1% | New | 2,600 | $814K |
| AP Alexion Pharmaceuticals Inc | 4.8% | Trimmed 28% | 6,199 | $760K |
| Regeneron Pharmaceuticals | 1.3% | New | 500 | $201K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2016 · filed November 07, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Edwards Lifesciences Corp | Added | +16,000 | +$1.93M | 26.1% |
| Align Technology Inc | Exited | −17,319 | −$1.4M | — |
| LE Lilly Eli & Co | Trimmed | −13,500 | −$1.08M | 6.7% |
| T Tesaro Inc | New | +10,000 | +$1M | 6.3% |
| Zoetis Inc | New | +15,900 | +$827K | 5.2% |
| Biogen Inc | New | +2,600 | +$814K | 5.1% |
| Acadia Pharmaceuticals Inc | Trimmed | −10,000 | −$318K | 14.5% |
| AP Alexion Pharmaceuticals Inc | Trimmed | −2,400 | −$294K | 4.8% |
| Dexcom Inc | Added | +2,500 | +$219K | 7.8% |
| Regeneron Pharmaceuticals | New | +500 | +$201K | 1.3% |
quarter ended June 30, 2016 · filed July 27, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Acadia Pharmaceuticals Inc | Added | +61,171 | +$1.99M | 20.8% |
| Johnson & Johnson | New | +13,000 | +$1.58M | 12.2% |
| Align Technology Inc | Added | +11,953 | +$963K | 10.8% |
| Regeneron Pharmaceuticals | Exited | −2,291 | −$826K | — |
| A Athenahealth Inc | Exited | −4,900 | −$680K | — |
| Dexcom Inc | Trimmed | −7,346 | −$583K | 7.2% |
| Edwards Lifesciences Corp | Added | +1,168 | +$116K | 14.3% |
quarter ended March 31, 2016 · filed May 12, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Edwards Lifesciences Corp | Trimmed | −20,879 | −$1.84M | 15.9% |
| Incyte Corp | Exited | −14,756 | −$1.6M | — |
| LE Lilly Eli & Co | Added | +17,912 | +$1.29M | 20.0% |
| Align Technology Inc | New | +5,366 | +$390K | 4.0% |
| AP Aerie Pharmaceuticals Inc | Exited | −14,962 | −$364K | — |
| Acadia Pharmaceuticals Inc | Trimmed | −8,249 | −$231K | 6.2% |
| Regeneron Pharmaceuticals | Trimmed | −625 | −$225K | 8.5% |
quarter ended December 31, 2015 · filed February 16, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Gilead Sciences Inc | Exited | −17,162 | −$1.69M | — |
| AP Alexion Pharmaceuticals Inc | New | +8,599 | +$1.64M | 15.1% |
| MC Medicines Co | Exited | −22,077 | −$838K | — |
| MP Mallinckrodt Pub Ltd Co | Exited | −12,769 | −$816K | — |
| Incyte Corp | Added | +7,412 | +$804K | 14.7% |
| M Medivation Inc | Exited | −18,794 | −$799K | — |
| A Athenahealth Inc | New | +4,900 | +$789K | 7.3% |
| Dexcom Inc | Added | +9,252 | +$758K | 14.4% |
| Neurocrine Biosciences Inc | Exited | −17,386 | −$692K | — |
| Acadia Pharmaceuticals Inc | Trimmed | −19,024 | −$678K | 9.8% |
Showing the 10 largest of 16 changes.
quarter ended September 30, 2015 · filed November 16, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Edwards Lifesciences Corp | New | +34,069 | +$4.84M | 28.5% |
| UH Universal Hlth Svcs Inc | Exited | −14,663 | −$2.08M | — |
| Gilead Sciences Inc | New | +17,162 | +$1.69M | 9.9% |
| Acadia Pharmaceuticals Inc | New | +48,825 | +$1.62M | 9.5% |
| AP Alexion Pharmaceuticals Inc | Exited | −5,949 | −$1.08M | — |
| T Thoratec Corp | Exited | −23,486 | −$1.05M | — |
| UT United Therapeutics Corp Del | Trimmed | −7,509 | −$985K | 1.9% |
| C Cynosure Inc | Exited | −25,475 | −$983K | — |
| AT Aratana Therapeutics Inc | New | +110,537 | +$935K | 5.5% |
| MC Medicines Co | New | +22,077 | +$838K | 4.9% |
Showing the 10 largest of 28 changes.
quarter ended June 30, 2015 · filed August 14, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| MC Medicines Co | Exited | −34,744 | −$974K | — |
| CC Cigna Corporation | New | +4,842 | +$784K | 4.6% |
| LA Laboratory Corp Amer Hldgs | Exited | −5,735 | −$723K | — |
| Incyte Corp | Exited | −7,742 | −$710K | — |
| C Cynosure Inc | Trimmed | −18,254 | −$704K | 5.7% |
| ZA Zeltiq Aesthetics Inc | New | +18,165 | +$535K | 3.1% |
| Humana Inc | Trimmed | −2,541 | −$486K | 4.3% |
| R Receptos Inc | New | +2,251 | +$428K | 2.5% |
| SG Seattle Genetics Inc | New | +8,768 | +$424K | 2.5% |
| AP Alexion Pharmaceuticals Inc | Added | +2,269 | +$410K | 6.2% |
Showing the 10 largest of 23 changes.
quarter ended March 31, 2015 · filed May 15, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| UT United Therapeutics Corp Del | Trimmed | −104,269 | −$18M | 11.7% |
| MP Mallinckrodt Pub Ltd Co | Trimmed | −136,531 | −$17.3M | 6.8% |
| Dexcom Inc | Trimmed | −250,744 | −$15.6M | 6.4% |
| Amgen Inc | Exited | −80,600 | −$12.8M | — |
| UH Universal Hlth Svcs Inc | Trimmed | −107,451 | −$12.6M | 11.4% |
| Regeneron Pharmaceuticals | Trimmed | −27,228 | −$12.3M | 6.8% |
| MC Medicines Co | Trimmed | −401,242 | −$11.2M | 6.1% |
| WP West Pharmaceutical Svsc Inc | Exited | −210,910 | −$11.2M | — |
| Align Technology Inc | Exited | −196,368 | −$11M | — |
| AP Alexion Pharmaceuticals Inc | Trimmed | −62,280 | −$10.8M | 4.0% |
Showing the 10 largest of 26 changes.
quarter ended December 31, 2014 · filed February 17, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AP Aegerion Pharmaceuticals Inc | Exited | −403,054 | −$13.5M | — |
| Johnson & Johnson | Exited | −122,361 | −$13M | — |
| Amgen Inc | New | +80,600 | +$12.8M | 5.9% |
| ZA Zeltiq Aesthetics Inc | Exited | −538,390 | −$12.2M | — |
| Regeneron Pharmaceuticals | New | +29,620 | +$12.2M | 5.6% |
| MC Medicines Co | New | +435,986 | +$12.1M | 5.5% |
| Align Technology Inc | New | +196,368 | +$11M | 5.0% |
| BI Biogen Idec Inc | Exited | −32,986 | −$10.9M | — |
| Acorda Therapeutics Inc | Exited | −303,484 | −$10.3M | — |
| HH Hca Holdings Inc | Exited | −144,586 | −$10.2M | — |
Showing the 10 largest of 32 changes.
Loading...
